Glenmede Trust’s Heron Therapeutics HRTX Stock Holding History

Glenmede Trust’s Portfolio HRTX Stock Details HRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$125K	Buy
2024 Q4	$60.6K	Buy
2024 Q3	$63.5K	Buy
2024 Q2	$74.6K	Buy
2024 Q1	$44.8K	Buy
2023 Q4	$20.2K	Buy